Abstract

Objectives: Considering the limitations and side effects of current synthetic medications, herein, the exploration of the anti-inflammatory and antihistamine properties of medicinal plants is conducted to provide alternative treatment options for asthma and aims to identify potential anti-asthmatic drugs using an in silico approach. Methods: A molecular docking study was performed to assess the binding affinities and interactions between the neuropeptide S receptor (NPSR) protein and 15 medicinal plants and flavonoids chosen from published literature. A Ramachandran Plot analysis was conducted to evaluate the stereochemical properties of the protein. Furthermore, to gain insights into the drug-likeness and pharmacokinetic properties of the identified ligands, ADMESAR analysis was performed to predict molecular properties and bioactivity of small molecules. Results: Among the 15 medicinal plants investigated in this research, Kaempferol exhibited the least binding energy of −5.05, indicating a highly stable interaction with the NPSR protein. This exceptional stability suggests that Kaempferol has the potential to serve as an effective anti-asthmatic drug. Conclusion: Asthma has no permanent cure, and the current synthetic medications raise long-term safety concerns. This study explored the use of medicinal plants and flavonoids, with Kaempferol showing promise as a potential anti-asthmatic drug candidate. This preliminary study could open avenues to further research and the use of medicinal plants in the treatment of asthma, potentially reducing reliance on synthetic drugs.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call